Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Gastrointestinal Neoplasms × Sorafenib × Clear all

Phase

Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 10 Refractory Solid Tumors 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Neurologic Manifestations 1 Neoplasms 1 Neoplasm Metastasis 1 Meningeal Carcinomatosis 1 Liver Neoplasms 1 Kidney Neoplasms 1 HCC 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1

Interventions

Surveys and Questionnaires 9 Endoscopic Mucosal Resection 5 Educational Status 5 Standard of Care 4 Diet Therapy 3 Blood Specimen Collection 3 Referral and Consultation 2 Quality of Life 2 Practice Guidelines as Topic 2 Palliative Care 2 Magnetic Resonance Spectroscopy 2 Interviews as Topic 2 Control Groups 2 Aprepitant 2 Acceptance and Commitment Therapy 2 vandetanib 1 fosaprepitant 1 dolasetron 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Weights and Measures 1 Tomography, X-Ray Computed 1 Therapeutics 1 Surgical Instruments 1 Sunitinib 1 Sorafenib 1 Sampling Studies 1 Restraint, Physical 1 Remote Patient Monitoring 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02013089 2016-08-30

GITIC

Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡